Cernum Biosciences Reveals Which Peptides Are Most Popular With Consumers

MEMPHIS, Tenn. - EntSun -- Cernum Biosciences today released a brief internal sales snapshot showing which peptides are drawing the strongest consumer interest across its catalog of all peptides.

The analysis found that Retatrutide is the most popular peptide, representing approximately 34% of demand. GHK-CU ranks second at approximately 24%. Together, those two products account for more than half of overall peptide demand.

A second tier of popularity includes CJC 1295 no DAC & Ipamorelin Blend at about 10% and BPC-157 at roughly 8%. At the other end of the ranking, the least popular peptides were Kisspeptin-10 and CJC-1295 (No DAC), each accounting for approximately 0.2% of demand, with IGF-1 LR3 also representing less than 1%.

More on EntSun News

• "Songs of Slavery and Emancipation" Tour Comes to John Brown's Hometown
• CAPHRA warns Southeast Asia not to repeat Australia's nicotine policy failure
• Milo3D.ai Launches Free AI 3D Model Generator That Turns Text and Images Into Game-Ready 3D Assets in Seconds
• UK Financial Ltd Executes 100% Success Rate on All ERC-3643 Transfers to Coin Holders of MayaCat Regulated Security Token and Maya Preferred PRA
• Blank Space: The Unofficial Taylor Swift Tribute Brings Eras Tour Magic To Cities Across America

The company said the data reflects clear customer preference for a small number of leading peptides while also showing continued interest across a broader specialty category. More information is available on the company's article about consumer trends.

About Cernum Biosciences

Cernum Biosciences is a purity-focused company dedicated to advancing access to high-quality peptides and supporting innovation in the life sciences sector.